SC 13G

Company

TScan Therapeutics, Inc.

Filed

February 10, 2022

Accession Number

0001193125-22-034689

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →